An allosteric modulator binds to a conformational hub in the β2 adrenergic receptor

被引:54
|
作者
Liu, Xiangyu [1 ,2 ]
Kaindl, Jonas [3 ]
Korczynska, Magdalena [4 ]
Stoessel, Anne [3 ]
Dengler, Daniela [3 ]
Stanek, Markus [3 ]
Huebner, Harald [3 ]
Clark, Mary J. [5 ]
Mahoney, Jake [5 ]
Matt, Rachel Ann [6 ]
Xu, Xinyu [2 ,7 ]
Hirata, Kunio [8 ,9 ]
Shoichet, Brian K. [4 ]
Sunahara, Roger K. [5 ]
Kobilka, Brian K. [2 ,6 ,7 ]
Gmeiner, Peter [3 ]
机构
[1] Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[2] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China
[3] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Med Chem, Erlangen, Germany
[4] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA
[5] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA
[6] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA
[7] Tsinghua Univ, Sch Med, Beijing, Peoples R China
[8] RIKEN SPring 8 Ctr Sayo Gun, SR Life Sci Instrumentat Unit, Res Infrastruct Grp, Adv Photon Technol Div, Sayo, Hyogo, Japan
[9] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan
关键词
DENSITY-FUNCTIONAL THEORY; G-PROTEIN; STRUCTURAL INSIGHTS; PK(A) PREDICTION;
D O I
10.1038/s41589-020-0549-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most drugs acting on G-protein-coupled receptors target the orthosteric binding pocket where the native hormone or neurotransmitter binds. There is much interest in finding allosteric ligands for these targets because they modulate physiologic signaling and promise to be more selective than orthosteric ligands. Here we describe a newly developed allosteric modulator of the beta(2)-adrenergic receptor (beta(2)AR), AS408, that binds to the membrane-facing surface of transmembrane segments 3 and 5, as revealed by X-ray crystallography. AS408 disrupts a water-mediated polar network involving E122(3.41) and the backbone carbonyls of V206(5.45) and S207(5.46). The AS408 binding site is adjacent to a previously identified molecular switch for beta(2)AR activation formed by I-3.40, P-5.50 and F-6.44. The structure reveals how AS408 stabilizes the inactive conformation of this switch, thereby acting as a negative allosteric modulator for agonists and positive allosteric modulator for inverse agonists.
引用
收藏
页码:749 / +
页数:12
相关论文
共 50 条
  • [41] Conformational transitions and allosteric modulation in a heteromeric glycine receptor
    Gibbs, Eric
    Klemm, Emily
    Seiferth, David
    Kumar, Arvind
    Ilca, Serban L.
    Biggin, Philip C.
    Chakrapani, Sudha
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [42] Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
    Billard, Etienne
    Torbey, Alexandre
    Inserra, Antonio
    Grant, Emily
    Bertazzo, Antonella
    De Gregorio, Danilo
    Comai, Stefano
    Chatenet, David
    Gobbi, Gabriella
    Hebert, Terence E.
    CELLULAR SIGNALLING, 2025, 127
  • [43] Conformational transitions and allosteric modulation in a heteromeric glycine receptor
    Eric Gibbs
    Emily Klemm
    David Seiferth
    Arvind Kumar
    Serban L. Ilca
    Philip C. Biggin
    Sudha Chakrapani
    Nature Communications, 14
  • [44] A Positive Allosteric Modulator of the Serotonin 5-HT2c Receptor for Obesity
    Garcia-Carceles, Javier
    Decara, Juan M.
    Vazquez-Villa, Henar
    Rodriguez, Ramon
    Codesido, Eva
    Cruces, Jacobo
    Brea, Jose
    Loza, Maria I.
    Alen, Francisco
    Botta, Joaquin
    McCormick, Peter J.
    Ballesteros, Juan A.
    Benhamu, Bellinda
    Rodriguez de Fonseca, Fernando
    Lopez-Rodriguez, Maria L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9575 - 9584
  • [45] The β2 subunit C loop of the nicotinic acetylcholine receptor directs allosteric modulator specificity
    Levandoski, M. M.
    Mack, A. R.
    Sibbald, C. A.
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (04) : 625 - 625
  • [46] Characterization of the Clinical Effect of a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor-2
    De Boer, Peter
    Sinha, Vikash
    Hoeben, Eva
    Anghelescu, Ion-George
    Kezic, Iva
    Daly, Ella
    Ceusters, Marc
    De Smedt, Heidi
    Van Nueten, Luc
    Kent, Justine M.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 319S - 319S
  • [47] Receptor polymorphisms determine the kinetics of β-adrenergic receptor conformational changes
    Ahles, A.
    Rochais, F.
    Lohse, M.
    Engelhardt, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 17 - 17
  • [48] CGP7930:: A positive allosteric modulator of the GABAB receptor
    Adams, C. L.
    Lawrence, A. J.
    CNS DRUG REVIEWS, 2007, 13 (03): : 308 - 316
  • [49] Mechanism of Allosteric Modulator Binding to the Adenosine A1 Receptor
    Miao, Yinglong
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 224A - 224A
  • [50] Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator
    Kaneko, Shun
    Imai, Shunsuke
    Uchikubo-Kamo, Tomomi
    Hisano, Tamao
    Asao, Nobuaki
    Shirouzu, Mikako
    Shimada, Ichio
    NATURE COMMUNICATIONS, 2024, 15 (01)